pembrolizumab,sacituzumab govitecan,zimberelimab,domvanalimab,avelumab
gilead sciences,merck,pfizer,arcus biosciences,otsuka
['#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'trophy,u-01']
looking forward to #gu23 rapid abstract presentation from - primary analysis of #trophy-u-01 cohort 2. #staytuned for written coverage on urotoday! 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology